Medical community finds ways to make TAVR safer for at-risk patients
April 15, 2019 12:00
Experts agree that transcatheter aortic valve replacement (TAVR) is a revolutionary and lifesaving treatment option for severe symptomatic aortic stenosis.

Dr. Jaffar M. Khan of the National, Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institute of Health (NIH), referred to TAVR as “one of the greatest achievements in interventional medicine in our lifetime,” but readily acknowledges that it is not safe for every patient.

Click here to read the full DOTmed News article
Log in to Reply
You must be logged in to comment.

Login Now